albendazole has been researched along with amphotericin b in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 8 (88.89) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Bhalgat, CM; Ramesh, B | 1 |
| Bharate, SS; Vishwakarma, RA | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Beisler, T; Kern, P; Reuter, S | 1 |
| Bastide, C; Bruyère, F; Chandenier, J; Desoubeaux, G; Fourcade, C; Guy, L; Karsenty, G; Lachaud, L; Lavigne, JP; Malavaud, S; Sotto, A | 1 |
| Jelicic, K; Papic, N; Vince, A; Viskovic, K | 1 |
2 review(s) available for albendazole and amphotericin b
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Non-antibiotic anti-infectious treatments in urology].
Topics: Acyclovir; Albendazole; Amphotericin B; Anti-Infective Agents; Caspofungin; Cidofovir; Cytosine; Echinocandins; Fluconazole; Flucytosine; Foscarnet; Ganciclovir; Humans; Ivermectin; Lipopeptides; Organophosphonates; Praziquantel; Urologic Diseases; Valganciclovir | 2013 |
7 other study(ies) available for albendazole and amphotericin b
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Novel dihydropyrimidines and its pyrazole derivatives: synthesis and pharmacological screening.
Topics: Animals; Anthelmintics; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Bacteria; Drug Evaluation, Preclinical; Fungi; Microbial Sensitivity Tests; Molecular Structure; Oligochaeta; Pyrazoles; Pyrimidines; Stereoisomerism | 2011 |
Thermodynamic equilibrium solubility measurements in simulated fluids by 96-well plate method in early drug discovery.
Topics: Drug Discovery; Pharmaceutical Preparations; Solubility; Thermodynamics | 2015 |
Combined albendazole and amphotericin B against Echinococcus multilocularis in vitro.
Topics: Albendazole; Amphotericin B; Animals; Anthelmintics; Cell Line; Drug Antagonism; Echinococcus multilocularis; Gerbillinae; Hepatocytes; Tissue Culture Techniques | 2010 |
Case Report: Amphotericin B and Mefloquine as a Salvage Treatment of Alveolar Echinococcosis.
Topics: Albendazole; Amphotericin B; Animals; Anthelmintics; Echinococcosis; Echinococcus multilocularis; Humans; Male; Mefloquine; Salvage Therapy | 2023 |